APA (7th ed.) Citation

Bavadekar, V. S., Joshi, A. M., & Desai, U. S. (2025). Application of the quality by design (QbD) approach to the development and validation of analytical methods for the quantification of Lumateperone Tosylate as the bulk drug and capsule dosage form by HPLC. Future Journal of Pharmaceutical Sciences, 11(1), 1. https://doi.org/10.1186/s43094-025-00779-6

Chicago Style (17th ed.) Citation

Bavadekar, Vasudha S., Angha M. Joshi, and Ujwala S. Desai. "Application of the Quality by Design (QbD) Approach to the Development and Validation of Analytical Methods for the Quantification of Lumateperone Tosylate as the Bulk Drug and Capsule Dosage Form by HPLC." Future Journal of Pharmaceutical Sciences 11, no. 1 (2025): 1. https://doi.org/10.1186/s43094-025-00779-6.

MLA (9th ed.) Citation

Bavadekar, Vasudha S., et al. "Application of the Quality by Design (QbD) Approach to the Development and Validation of Analytical Methods for the Quantification of Lumateperone Tosylate as the Bulk Drug and Capsule Dosage Form by HPLC." Future Journal of Pharmaceutical Sciences, vol. 11, no. 1, 2025, p. 1, https://doi.org/10.1186/s43094-025-00779-6.